Low Water Intake and Risk for New-Onset Hyperglycemia
Open Access
- 14 November 2011
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (12), 2551-2554
- https://doi.org/10.2337/dc11-0652
Abstract
OBJECTIVE Water intake alters vasopressin secretion. Recent findings reveal an independent association between plasma copeptin, a surrogate for vasopressin, and risk of diabetes. RESEARCH DESIGN AND METHODS Participants were 3,615 middle-aged men and women, with normal baseline fasting glycemia (FG), who were recruited in a 9-year follow-up study. Odds ratios (ORs) and 95% CIs for the incidence of hyperglycemia (FG ≥6.1 mmol/L or treatment for diabetes) were calculated according to daily water intake classes based on a self-administered questionnaire. RESULTS During follow-up, there were 565 incident cases of hyperglycemia. After adjustment for confounding factors, ORs (95% CIs) for hyperglycemia associated with classes of water intake (n = 677; 0.5 to 1.0 L, n = 1,184) were 1.00, 0.68 (0.52–0.89), and 0.79 (0.59–1.05), respectively (P= 0.016). CONCLUSIONS Self-reported water intake was inversely and independently associated with the risk of developing hyperglycemia.Keywords
This publication has 15 references indexed in Scilit:
- Plasma Copeptin and the Risk of Diabetes MellitusCirculation, 2010
- Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohortKidney International, 2010
- Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of γ-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)Diabetologia, 2009
- Predicting Diabetes: Clinical, Biological, and Genetic ApproachesDiabetes Care, 2008
- Vasopressin Stimulates Insulin Release from Islet Cells through V1b Receptors: a Combined Pharmacological/Knockout ApproachMolecular Pharmacology, 2004
- Pancreatic vasopressin V1breceptors: characterization in In-R1-G9 cells and localization in human pancreasAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Binding of (3H) SR 49059, a Potent Nonpeptide Vasopressin V1a Antagonist, to Rat and Human Liver MembranesBiochemical and Biophysical Research Communications, 1994
- Localization of Vasopressin Binding Sites in Rat Tissues Using Specific Vi and V2 Selective Ligands*Endocrinology, 1990
- THE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MANClinical Endocrinology, 1985
- Plasma Vasopressin in Uncontrolled Diabetes MellitusDiabetes, 1979